It's not bad advice if you think about it. Market cap is about $2m with cash of $2m. They will be entitled to an R&D refund and the burn is going to be low. It could do ok if they were to announce a deal/RTO etc.
I just bought more (not advocating others to but my parcel was small and I was able to increase it significantly with a reasonably small outlay). Biotechs generally tend to have a massive overreaction on negative news so hoping it bounces tomorrow. Doubt it will go up that quickly but we'll see.
I definitely agree with super that it is worth a punt on the shell alone. That's all I seem to be investing in (shells) at the moment
- Forums
- ASX - By Stock
- DLM
- Ann: Results of Phase 2 Clinical Trial
Ann: Results of Phase 2 Clinical Trial, page-97
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online